In this roundtable discussion with Dr. John Gribben, University of London, and Dr. Constantine Tam, Peter MacCallum Cancer Centre, Patient Power Founder, Andrew Schorr, asks the panelists to discuss the current frontline treatment advances for CLL. Listen as new research is discussed, including survival advantages and durable control, as well as cumulative toxicity and cost.
Where Are We Headed With Frontline CLL... - CLL America Support
Where Are We Headed With Frontline CLL Treatment Approaches?
Written by
mcints
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Hubby about to begin Obinutuzumab infusions....feeling anxious
Aloha! My husband (age 74) was diagnosed with CLL back in 2003 and had eighteen years of zero...
Choice of doctors
Ok so I've got a real dilemma. I'm on W&W. I have two top CLL specialists in two sister hospitals....
New here. After 10 years of CLL, Ibrutinib treatment needed for decreasing hemoglobin and platelets.
I have avoided any treatment so far but extreme fatigue fluctuations have drastically restricted...
Venetoclax and spleen enlarging
My husband is on an ibrutinib venetoclax combo trial. His spleen reduced after initial few months...
Anxiety
Not feeling very confident with the Dr that I have been referred to. Problem is where I live it is...
Treatmant for cll
I’m unclear what to think of my diagnosis
Good News from the Doctor Venetoclax is working!
Low Platelets
CLL diagnosis and diet